Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 7, 2023
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
Mitchell Kapoor Maintained (TYRA) at Strong Buy with Increased Target to $17 on, Mar 7th, 2023
Mitchell Kapoor of HC Wainwright & Co., Maintained "Tyra Biosciences, Inc." (TYRA) at Strong Buy with Increased Target from $15 to $17 on, Mar 7th, 2023.
Mitchell has made no other calls on TYRA in the last 4 months.
There is 1 other peer that has a rating on TYRA. Out of the 1 peers that are also analyzing TYRA, 0 agree with Mitchell's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mitchell
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $17 on, Friday, February 3rd, 2023
